Experiments aimed at silencing HK2 in human embryonic kidney cells, liver cancer cells, mouse mononuclear macrophages, and immortalized bone marrow macrophages have demonstrated a reduction in glycolysis as indicated by decreased levels of pyruvate and lactic acid 93. Here, HK2 is linked to liver cancer.